Ведение пациентов с хронической неспецифической поясничной болью

Журнал "Медицинский совет." №1, 2019

DOI: https://doi.org/10.21518/2079-701X-2019-1-40-45

В.А. ПАРФЕНОВ - Федеральное государственное автономное образовательное учреждение высшего образования «Первый Московский государственный медицинский университет имени И.М. Сеченова» Министерства здравоохранения Российской Федерации (Сеченовский университет)

Хронические поясничные боли (ПБ) представляют одну из наиболее частых причин временной нетрудоспособности населения. При обследовании пациентов большое значение имеет как исключение специфических причин боли, так и оценка социальных и психологических факторов поддержания боли. При ведении пациентов с хронической неспецифической ПБ эффективен комплексный мультидисциплинарный подход, который включает рационализацию лекарственной терапии, лечебную гимнастику, коррекцию (при необходимости) рабочего места и двигательной активности, психологические методы и образовательную программу. Из лекарственных средств в период комплексного лечения наиболее часто используются нестероидные противовоспалительные средства (НПВС). Обсуждается применение в качестве НПВС ибупрофена медленного высвобождения при хронической неспецифической ПБ.

Parfenov Vladimir Anatolievich – Dr. of Sci. (Med), Professor, Head of the Department of Nervous Diseases and Neurosurgery of the Federal State Autonomous Educational Institution of Higher Education «First Moscow State Medical University named after I.M. Sechenov» of the Ministry of Health of the Russian Federation (Sechenov University), Director of the Clinic of Nervous Diseases named after A.Y. Kozhevnikov of the First Moscow State Medical University named after I.M. Sechenov

Chronic lumbar pain (CLP) is one of the most common causes of temporary disability. Both the elimination of specific causes of pain and the assessment of social and psychological factors of pain management are of great importance in the examination of patients. A comprehensive multidisciplinary approach is effective in managing patients with chronic nonspecific LP, which includes rationalization of drug therapy, therapeutic gymnastics, correction (if necessary) of the workplace and motor activity, psychological methods and educational program. Non-steroidal anti-inflammatory drugs (NSAIDs) are the drugs most commonly used during the integrated treatment period. The use of slow release ibuprofen as a NSAID in chronic non-specific LP is discussed.

Литература / References:

1. Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386:743-800.
2. Jordan K.P., Kadam U.T., Hayward R., et al. Annual consultation prevalence of regional musculoskeletal problems in primary care: an observational study. BMC Musculoskelet Disord. 2010;11:144.
3. Hoy D., Brooks P., Blyth F., Buchbinder R. The Epidemiology of low back pain. Best Pract Res Clin Rheumatol. 2010;24(6):769-871.
4. Vos T., Flaxman A.D., Naghavi M., et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2163-2196.
5. Koes B.W., van Tulder M., Lin C.W., et al. An updated overview of clinical guidelines for the management of non-specific low back pain in primary care. Eur Spine J. 2010;1 9(12):2075-2094.
6. Парфенов В.А., Исайкин А.И. Поясничные боли. М., 2018. 195 с.
7. Chou R., Qaseem A., Snow V., et al. Diagnosis and treatment of low back pain: a joint clinical practice guideline from the American College of Physicians and the American Pain Society. Ann Intern Med. 2007;147:478-491.
8. Kendall N.A., Linton S.J, Main C.J. Guide to assessing psychosocial yellowflags in acute low back pain: risk factors for long-term disability and work loss. Accident Rehabilitation. Compensatio Insurance Corporation of New Zealand and the National Health Committee. Wellington, New Zealand, 1997.
9. Подчуфарова Е.В., Яхно Н.Н. Боль в спине. М., 2010. 368 с.
10. Wong J., Côté P., Sutton D.A., et al. Clinical practice guidelines for the noninvasive management of low back pain: A systematic review by the Ontario Protocol for Traffic Injury Management (OPTIMa) Collaboration. Eur J Pain. 2017;21(2):201-216.
11. Low Back Pain and Sciatica in Over 16s: Assessment and Management. Clinical Guidelines. London: National Institute for Health and Care Excellence (UK); 2016. www. http://nice.org.uk/guidance/ng5.
12. Stochkendahl M.J., Kjaer P., Hartvigsen J., et al. National Clinical Guidelines for non-surgical treatment of patients with recent onset low back pain or lumbar radiculopathy. Eur Spine J. 2018;27(1):60-75.
13. Qaseem A., Wilt T.J., McLean R.M., Forciea M.A. Noninvasive Treatments for Acute, Subacute, and Chronic Low Back Pain: A Clinical Practice Guideline From the American College of Physicians. Ann Intern Med. 2017;166(7):514-530.
14. Hooten W.M., Cohen S.P. Evaluation and Treatment of Low Back Pain: A Clinically Focused Review for Primary Care Specialists. Mayo Clin Proc. 2015;90(12):1699-1718.
15. Itz C.J., Willems P.C., Zeilstra D.J., Huygen F.J. Dutch Multidisciplinary Guideline for Invasive Treatment of Pain Syndromes of the Lumbosacral Spine. Pain Pract. 2016;15:90-110.
16. Hartvigsen L., Kongsted A., Hestbaek L. Clinical examination findings as prognostic factors in low back pain: a systematic review of the Literature. Manual Therapies. 2015;23:13.
17. Kamper S.J., Apeldoorn A.T., Chiarotto A., et al. Multidisciplinary biopsychosocial rehabilitation for chronic low back pain: Cochrane systematic review and meta-analysis. BMJ. 2015;350:h444.
18. Hong J.-Y., Son K.-S., Cho J.H., Lee J.H. An Updated Overview of Low Back Pain Management in Primary Care. Asian Spine J. 2017;11(4):653-660.
19. Pillastrini P., Ferrar S., Rattin S., et al. Exercise and tropism of the multifidus muscle in low back pain: a short review. J. Phys. Ther. Sci. 2015;27:943-945.
20. O’Connor S.R., Tully M.A., Ryan B., et al. Walking exercise for chronic musculoskeletal pain: systematic review and meta-analysis. Arch Phys Med Rehabil. 2015;96(4):724-734.
21. Hendrick P., Te Wake A.M., Tikkisetty A.S., et al. The effectiveness of walking as an intervention for low back pain: a systematic review. Eur Spine J. 2010;19:1613-1620.
22. Airaksinen O., Brox J.I., Cedraschi C., et al. European guidelines for the management of chronic nonspecific low back pain. Eur Spine J. 2006;15(Suppl. 2):S192-S300.
23. Rubinstein S.M., van Middelkoop M., Assendelft W.J., et al. Spinal manipulative therapy for chronic low-back pain: an update of a Cochrane review. Spine (Phila Pa 1976). 2011;13: E825-Е846.
24. Liu L., Skinner M., McDonough S., et al. Acupuncture for Low Back Pain: An Overview of Systematic Reviews. Evidence-Based Complementary and Alternative Medicine. 2015:ID328196. 18 p.
25. Hutchinson A., Ball S., Andrews J., Jones G.G. The effectiveness of acupuncture in treating chronic non-specific low back pain: a systematic review of the literature. Journal of Orthopaedic Surgery and Research. 2012;7:36-44.
26. Furlan A.D., Giraldo M., Baskwill A., et al. Massage for low-back pain. Cochrane Database Syst Rev. 2015;CD001929.
27. Kuijpers T., van Middelkoop M., Rubinstein S.M., et al. A systematic review on the effectiveness of pharmacological interventions for chronic non-specific low-back pain. Eur Spine J. 2011;20:40-50.
28. Kuritzky L., Samraj G.P. Nonsteroidal antiinflammatory drugs in the treatment of low back pain. Journal of Pain Research. 2012;5:579- 590.
29. Enthoven W.T., Roelofs P.D., Deyo R.A., van Tulder M.W., Koes B.W. Non-steroidal antiinflammatory drugs for chronic low back pain. Cochrane Database Syst Rev. 2016 Feb 10;2:CD012087.
30. Piccoliori G., Engl A., Gatterer D., et al. Management of low back pain in general practice - is it of acceptable quality: an observational study among 25 general practices in South Tyrol (Italy). BMC Family Practice. 2013;14:148-156.
31. Hodkinson D.J., Khawaja N., O’Daly O. et al. Cerebral analgesic effect to nonsteroidal antiinflammatory agent ibuprofen. Pain. 2015;156:1301-1310.
32. Moore R.A., Derry S., Wiffen P.J., Straube S., Aldington D.J. Overview review: Comparative efficacy of oral ibuprofen and paracetamol (acetaminophen) across acute and chronic pain conditions. Eur J Pain. 2015;19(9):1213-1223.
33. Nunn M.L., Hayden J.A., Magee K. Current management practices for patients presenting with low back pain to a large emergency department in Canada. BMC Musculoskelet Disord. 2017;18:92.
34. Khalifa N., El-Husseini T., Morrah A. et al. Use of ibuprofen sustained release for treating osteoarthritis pain: findings from 15 medical general practices Egypt. Open access rheumatology: research and reviews. 2014;6:49-56.
35. Driessens M., Famaei J-P., Orloff S. et al. Efficasy and tolerability of sustained release ibuprofen in the treatment patients with chronic back pain. Curretnt therapeutic research. 1994;55:1283-1292.
36. Baumgartner H., Schwartz H.A., Blum W. Et al. Ibuprofen and diclofenac sodium in the treatment osteoarthritis: a comparative study of two once-daily sustained-released NSAID formulation. Curretnt Medical Research and Opinion. 1996;13:435-444.
37. Manchikanti L., Abdi S., Atluri S., et al. An update of comprehensive evidence-based guidelines for interventional techniques in chronic spinal pain. Part II: guidance and recommendations. Pain Physician. 2013;16(2 Suppl):S49-S283.